The "2016 Tumor Comprehensive Treatment New Technology Academic Seminar and Network Consultation Platform Exchange Meeting" was held in the First Hospital of Nanjing. Many well-known scholars at home and abroad exchanged and discussed on the minimally invasive tumor diagnosis and treatment and medical Internet. At the meeting, Chen Jinfei, director of the Department of Oncology, Chief Physician and Doctoral Supervisor of the First Hospital of Nanjing, published the article entitled "MDT (Multidisciplinary Consultation) in the Diagnosis and Treatment of Cancer". The Chief Physician of Cancer Department, Dr. Tang Aiju conducted medical Internet + experience. Explore.
It is understood that at the beginning of the year, Tang Cuiju conducted a video consultation on the cancer patient Wu Ji (pseudonym) in Hongze County, Huai'an, through the telemedicine service platform, to provide him with professional and clear diagnostic opinions and treatment plans. This video interview has not only created the hospital's chance to save the lives of cancer patients, but also realized the practice of online referrals for intractable diseases and transfer to offline treatment.
Tang Cuiju said that it is not terrible to suffer from cancer. The most terrible thing is that the most accurate and timely treatment plan is not obtained, leading to misdiagnosis and mistreatment. Chen Jinfei also said that the Department of Oncology currently uses the Internet platform for multi-disciplinary consultation of online video. Second-level hospitals in Anhui and Northern Jiangsu transmit patient data to the hospital through the remote consultation platform. After the hospital integrates the relevant department experts to view the medical information, Multidisciplinary consultation (MDT). The development of multidisciplinary consultations provides patients with a comprehensive assessment based on maximizing the provision of better, more effective and more convenient services for patients to maximize their benefits.
Palatin Technologies Inc. (NYSE: PT-141) announced today that it has shown positive results in a Phase I clinical trial of pT-141 for the treatment of sexual dysfunction in normal premenopausal women.
The trial included 32 healthy female volunteers and evaluated their response to pT-141 and placebo in response to visual stimuli. Pt-141 was found to be safe and resulted in a significantly greater improvement in vaginal blood flow than placebo users (P< 0.05).
role
Such antibiotics first affect the outer membrane of sensitive bacteria. Drug ring part of polypeptide amino and lipopolysaccharide in the outer membrane 2 valence cations combining site to produce electrostatic interaction, destroy the integrity of the outer membrane damage, fatty acid part of drugs to penetrate the outer membrane, thus increase the permeability of cell size, lead to intracytoplasmic phosphate, nucleosides and other small molecules to escape, straight die cause cell dysfunction. Gram-positive bacteria do not respond to such antibiotics because they have a thick cell wall that prevents drugs from entering the bacteria.
Pt141 Powder,Bodybuilding Ipamorelin,Sermorelin Powder,Weight Loss Peptide
Shaanxi YXchuang Biotechnology Co., Ltd , https://www.peptide-nootropic.com